THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
@Large

Nanotech, biotech at key juncture

By Scott Kirsner
Globe Columnist / March 22, 2004

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail|
  • Print|
  • Reprints|
  • |
Text size +

What the world needs now is a cheaper buckyball. At least that's what Gordon Fowler believes. Fowler is the chief executive of a start-up called Nano-C, which produces molecules called buckminsterfullerenes, or buckyballs. They sound funny, but one day they could save your life. (Full Article: 922 Words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 Article
  • $9.95 4 Articles
  • $99.95 Unlimited